South Africa asks COVID-19 vaccine manufacturers to delay delivery
South Africa has asked manufacturers of COVID-19 vaccines to delay delivery until next year as the country has sufficient stock, the Health Ministry said on Wednesday.
Department of Health spokesperson Foster Mohale said the country has stocks to last it the next three months.
“Our priority is demand creation to encourage more people to vaccinate ahead of the festive period. We are accelerating our efforts to reach more people ahead of the anticipated 4th wave to minimize its impact,” said Mohale.
The government has been battling vaccine hesitancy and has been pulling out all the stops to boost the rate of administered doses. It launched weekend vaccines drives, pop-up vaccination centres, and partnered with community and traditional leaders to encourage more South Africans to get vaxxed.
Vaccine hesitancy fight continues
The latest official statistics show that 35 percent of South Africans are fully vaccinated. The government had set a target of vaccinating 70 percent of the adult population by year-end.
“We may not meet the 70% target by the look of things, but we will double our efforts to come closer to it,” he said.
Mohale emphasised that delaying delivery would not result in a shortage of vaccines later on and that there was enough stock to handle any potential uptick in demand.
There is more than enough stock
“We can vaccinate 30 percent (of South Africans needed to reach the 70 percent target) and another 20 percent. As long as people come forward, we will never run out of vaccines, based on the current stock levels l,” he told Health-e News.
He did not say when deliveries would take place but manufacturers would be notified when the need arises. South Africa is currently administering the J&J and the Pfizer vaccine to the population.
We won’t wait until the last minute, we monitor stock levels regularly”, he said.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
South Africa asks COVID-19 vaccine manufacturers to delay delivery
by Kalayvani Nair, Health-e News
November 24, 2021